# Cyclic innovation to drive the Atrial Fibrillation Devices Market
Author:  Pal Sinha, Barnali 
Author URL: https://financedigest.com/author/pal-sinha-barnali
Published: 2021-11-18
Category: Research Reports
Category URL: https://financedigest.com/category/research-reports
Meta Title: Atrial Fibrillation Devices Market Growth & Trends Report
Meta Description: Discover how SMAC and IoT are reshaping the industry, with innovative techniques and minimally-invasive procedures driving market growth. Get valuable insights
URL: https://financedigest.com/cyclic-innovation-to-drive-the-atrial-fibrillation-devices-markethtml

![undefined](https://prod.superblogcdn.com/site_cuid_cm5qst7v3003gwirgwqtxn8i8/images/research-report-1736837172734-compressed.jpg)

The Atrial Fibrillation Devices Market is expected to grow by leaps and bounds In Upcoming Years. With digital convergence coming across as a pivot, the entire ecosystem inclusive of OEMs, providers, payers, and various other intermediaries is in the orbit. These value-based, end-user-centric models are the focal point. SMAC and IoT are being leveraged to [build scalable connected digital platforms](https://www.financedigest.com/lending-stream-builds-leading-edge-credit-platform-with-fico-analytic-software.html "Lending Stream Builds Leading-Edge Credit Platform with FICO Analytic Software"). This is the running [trend and is expected](https://www.financedigest.com/what-to-expect-in-2022-financial-services-trends-according-to-salesforce.html "What to expect in 2022? Financial Services Trends, according to Salesforce") to be in continuation in the forecast period.

Interventional electrophysiology devices have already had a significant impact on patients suffering from cardiac arrhythmias, and are being increasingly adopted as a permanent treatment option for atrial fibrillation. Procedures such as radiofrequency ablation, cryoablation, and cox-maze are well performed in today’s practice. Recent studies have found cryoablation to be more effective than medical management, and it is widely used in medical surgical practice.

**Planning Forward? Access Sample Of Atrial Fibrillation Devices Market Report!** [**https://www.persistencemarketresearch.com/samples/31531**](https://www.persistencemarketresearch.com/samples/31531)

The overall [market is primarily driven by the growing](https://www.financedigest.com/fibre-to-the-home-market-to-grow-at-a-high-14-4-cagr.html "Fibre to the Home Market to grow at a high 14.4% CAGR") prevalence of atrial fibrillation amongst the geriatric as well as adult population, and the adoption of minimally-invasive techniques for the permanent treatment of atrial fibrillation. Moreover, the use of innovative techniques, advancements in technology, and favorable reimbursement scenario are some other factors responsible for propelling the growth of the [**atrial fibrillation devices market**](https://www.persistencemarketresearch.com/market-research/atrial-fibrillation-devices-market.asp).

As such, the global atrial fibrillation [devices market](https://www.financedigest.com/the-npwt-devices-and-dressings-market-to-have-growth-devised-on-innovation.html "The NPWT Devices And Dressings Market to have growth devised on innovation") is estimated to be valued at **US$ 3.9 Bn** in 2020, with the market expected to exhibit a healthy **CAGR of more than 14%** during the forecast period ( **2020-2030**).

**Company Profiles:**

- Biosensense Webster, Inc. (Johnson & Johnson)
- Abbott Laboratories
- Medtronic Plc
- Boston Scientific Corporation
- AtriCure, Inc.
- Japan Lifeline Co.
- Biotronik, Inc
- MicroPort Scientific Corporation
- Biomerics
- CathRx

**Get A Customized Scope To Match Your Need Ask An Expert –** [**sales@persistencemarketresearch.com**](mailto:sales@persistencemarketresearch.com)

**How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Atrial Fibrillation Devices Market?** [**https://www.persistencemarketresearch.com/methodology/31531**](https://www.persistencemarketresearch.com/methodology/31531)

**Key Takeaways from Atrial Fibrillation [Devices Market](https://www.financedigest.com/thermal-ablation-devices-market.html "Thermal Ablation Devices Market") Study**

- The diagnostics segment, by product, is [expected to gain maximum revenue share over the forecast period](https://www.financedigest.com/wind-turbine-generator-market-is-expected-to-reach-net-valuation-of-more-than-us-90-7bn-during-forecast-period-of-2021-to-2031.html "Wind Turbine Generator Market Is Expected To Reach Net Valuation Of More Than US$ 90.7Bn During Forecast Period Of 2021 To 2031"). The therapeutic segment is anticipated to increase at a CAGR of **15%** over **2020**– **2030**, to reach **US$ 8.3** Bn by **2030**.
- According to PMR data collected from electrophysiologists in various regions, radiofrequency [catheter ablation is the procedure](https://www.financedigest.com/increase-minimally-invasive-procedures-will-drive-chronic-total-occlusion-catheter-market-demand.html "Increase Minimally Invasive Procedures Will Drive Chronic Total Occlusion Catheter Market Demand") of choice due to the high success rate, while cryoablation is the second preference for atrial fibrillation catheter ablation.
- By technology, the radiofrequency and cryoablation segments, collectively held more than **70%** [market share in terms of revenue](https://www.financedigest.com/chemical-injection-metering-pumps-valves-market-to-surge-at-a-robust-pace-in-terms-of-revenue-over-2021-2031.html "Chemical Injection Metering Pumps & Valves Market to Surge at a Robust Pace in Terms of Revenue over 2021 – 2031") in **2019**.

Among all end users, hospitals is the leading segment, which is followed by cardiac catheterization laboratories. The hospitals segment is anticipated to expand at a CAGR of **14%** over the forecast period.- North America and Europe, collectively held more than **70%** revenue share in **2019**, while South Asia is expected to show greater [growth potential over the forecast period](https://www.financedigest.com/servo-press-market-to-register-a-robust-growth-rate-during-the-forecast-period-2017-2025.html "Servo Press Market to Register a Robust Growth Rate During the Forecast Period 2017 – 2025").
- With the ongoing **Covid-19** pandemic wreaking havoc across the world, other non-emergency treatments have been deprioritized. As such in the near-term, the growth of the atrial fibrillation devices [market will be slower than the average for the decade ahead](https://www.financedigest.com/a-look-ahead-to-2023-in-the-insurance-market.html "A Look Ahead to 2023 in the Insurance Market").

**_“New product approvals and launches of ablation catheters along with increasing demand for minimally-invasive procedures offering increased longevity and safety profiles are [driving the growth](https://www.financedigest.com/open-architecture-innovation-will-drive-new-growth-for-insurers-according-to-aon-gimo-report.html "‘Open architecture innovation’ will drive new growth for insurers, according to Aon GIMO report") of the global atrial fibrillation devices market,”_** says a PMR analyst.

**New Product Launches – Key Strategic [Focus of Market](https://www.financedigest.com/pallet-pooling-market-to-cross-us-11-bn-mark-by-2029-backed-by-rising-focus-on-lean-supply-management.html "Pallet Pooling Market to Cross US$ 11 Bn Mark by 2029, Backed by Rising Focus on Lean Supply Management") Players**

Product [approvals by the FDA for new AF devices](https://www.financedigest.com/eu-commission-approves-delay-in-medical-devices-law-to-avert-shortages.html "EU commission approves delay in medical devices law to avert shortages") are responsible for intense competition among market players. Numerous [organizations are focusing on new product launches](https://www.financedigest.com/world-tourism-organization-unwto-and-sommet-education-launch-hospitality-challenge-pitch.html "World Tourism Organization (UNWTO) and Sommet Education launch Hospitality Challenge Pitch") for electrophysiology, especially for atrial fibrillation. For instance, in **August 2016**, Biosense Webster, Inc., a world leader in the treatment and diagnosis of heart arrhythmias, [announced the launch](https://www.financedigest.com/pega-pool-announces-the-official-launch-of-its-eco-friendly-bitcoin-mining-pool.html "PEGA Pool Announces the Official Launch of Its Eco-friendly Bitcoin Mining Pool") of THERMOCOOL SMARTTOUCH SF catheters with contact force technology and a porous tip designed to optimize the treatment of atrial fibrillation. Also, in **January 2019**, Abbott announced FDA approval for the TactiCath Contact Force Ablation Catheter. These winning strategies by leading players in the atrial fibrillation [devices market](https://www.financedigest.com/orthopedic-trauma-devices-market-is-slated-to-rise-at-a-cagr-of-6-9-to-close-in-on-us-14-8-billion-by-2028.html "Orthopedic Trauma Devices Market is slated to rise at a CAGR of 6.9% to close in on US$ 14.8 Billion by 2028") are also being followed by regional and local players.

**Planning To Introduce An Offbeat Product/Technology In The Atrial Fibrillation Devices Market? Go To “Purchase Now” To Have Our Atrial Fibrillation Devices Market Report!** [**https://www.persistencemarketresearch.com/checkout/31531**](https://www.persistencemarketresearch.com/checkout/31531)

**Atrial Fibrillation [Devices Market:](https://www.financedigest.com/cotinine-screening-devices-market-is-expected-to-increase-at-a-robust-cagr-of-5-during-2019-2029.html "Cotinine Screening Devices Market is expected to increase at a Robust CAGR of 5% during 2019-2029") Competition Landscape**

The global [market is set to broaden its scope during the forecast](https://www.financedigest.com/agriculture-industry-is-anticipated-to-drive-dairy-concentrates-market-demand-over-forecast-2028.html "Agriculture Industry Is Anticipated To Drive Dairy Concentrates Market Demand Over Forecast 2028") period, stimulated by the rising prevalence of AF, worldwide. In addition, a [favorable reimbursement scenario and increasing demand for minimally-invasive procedures have augmented the sales](https://www.financedigest.com/most-twitter-shareholders-vote-in-favor-of-sale-to-musk-sources.html "Most Twitter shareholders vote in favor of sale to Musk-sources") of atrial fibrillation devices.

The market is dominated by **4** major manufacturers – Biosense Webster, Inc. (Johnson & Johnson), Abbott Laboratories, Medtronic Plc, and Boston Scientific Corporation, with a revenue share of over **70%** in **2019**. These major manufacturers are focusing on manufacturing electrophysiology devices used specifically for atrial fibrillation procedure, such as ablation devices, intracardiac echocardiography catheters, and left atrial appendage (LAA) management devices. Key market players covered by PMR include Biosense Webster, Inc. (Johnson & Johnson), Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, ArtiCure, Inc., Japan Lifeline Co., Biotronik SE & Co. KG, Biomerics, MicroPort Corporation, and CathRx, who are consolidating their position through mergers, acquisitions, and new product launches.

**Want more insights?**

PMR brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels, and provides an analysis of the latest [industry trends](https://www.financedigest.com/the-finance-industry-a-look-at-trends-and-predictions-for-2021.html "The finance industry – A look at trends and predictions for 2021") in each of the sub-segments from **2015** to **2030**. The global atrial fibrillation devices market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader **.** The study provides compelling insights on the atrial fibrillation devices market on basis of product (diagnostics – conventional EP catheters, mapping catheters, CS catheters, and ICE catheters) and therapeutics – EP ablation, maze surgery, and LAA management devices), technology (radiofrequency, crythotherapy, ultrasound, and others), and end user (hospitals, ambulatory surgical centers, and cardiac catheterization laboratories), across seven major regions.

**Related Reports:**

[**Angiography Catheters Market**](https://www.persistencemarketresearch.com/market-research/angiography-catheters-market.asp)

[**Cardiac Marker Analyzer Market**](https://www.persistencemarketresearch.com/market-research/cardiac-marker-analyzer-market.asp)

**About Us:** [**Persistence Market Research**](https://www.persistencemarketresearch.com/about-us.asp)

**Contact Us:**

**Persistence Market Research**

Address – 305 Broadway, 7th Floor, New York City,

NY 10007 United States

U.S. Ph. – +1-646-568-7751

USA-Canada Toll-free – +1 800-961-0353

**Japan Office:** 1-2-1 Kinshi Arca Central Building

14/F Tokyo, 130-0013, Japan

Call 1-888-863-3700

**Sales** – sales@persistencemarketresearch.com

**Website** – [https://www.persistencemarketresearch.com](https://www.persistencemarketresearch.com/)


---
This blog is powered by Superblog. Visit https://superblog.ai to know more.
---